← Back to Search

Ceramic Material

Celtra Duo for Unsatisfactory Tooth Restoration

N/A
Waitlist Available
Led By Dennis J Fasbinder, DDS
Research Sponsored by University of Michigan
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 years
Awards & highlights
No Placebo-Only Group

Summary

This trial tests a new strong ceramic material for dental crowns. It focuses on adults needing crowns on their back teeth. The crowns are made and attached using two different methods to see which is better. The study will check the crowns' performance over time.

Eligible Conditions
  • Cavity
  • Broken Tooth
  • Unsatisfactory Tooth Restoration

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 years for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Crown Failure
Secondary study objectives
Crown Loss of Retention
Margin Staining
Tooth Sensitivity

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Group I: Hand Polished, Calibra UniversalExperimental Treatment1 Intervention
Celtra Duo crowns will be hand-polished and cemented with Calibra Universal Cement
Group II: Glazed Fired, Calibra CéramExperimental Treatment1 Intervention
Celtra Duo crowns will be glaze-fired in a porcelain oven and cemented with Calibra Ceram Cement

Find a Location

Who is running the clinical trial?

University of MichiganLead Sponsor
1,853 Previous Clinical Trials
6,432,944 Total Patients Enrolled
Dentsply Sirona Inc.Industry Sponsor
2 Previous Clinical Trials
106 Total Patients Enrolled
Dennis J Fasbinder, DDSPrincipal InvestigatorUniversity of Michigan
1 Previous Clinical Trials
30 Total Patients Enrolled
~7 spots leftby Nov 2025